|
Citation
2005, Vol. 46, No. 7, Pages 1085-1089
, DOI 10.1080/10428190500062932
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendationsJoanna K Law1Department of Medicine, University of British Columbia, Vancouver, Canada 2Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada Forward Links to Citing ArticlesTimucin Cil, Abdullah Altintas, Yekta Tuzun, Semir Pasa, Abdurrahman Isikdogan. (2007) Hepatitis B virus reactivation induced by Yttrium-90-ibritumomab-tiuxetan. Leukemia & Lymphoma 48:9, 1866-1868 Online publication date: 1-Jan-2007. Citation | Full Text | PDF (63 KB) | PDF Plus (63 KB) Sercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, Didem Sener Dede, Omer Dizdar, Kadri Altundag, Ibrahim Barista. (2007) Rituximab-related viral infections in lymphoma patients. Leukemia & Lymphoma 48:7, 1307-1312 Online publication date: 1-Jan-2007. Summary | Full Text | PDF (85 KB) | PDF Plus (85 KB) Anjum S. Kaka, Cliona M. Rooney, Barbara Savoldo. (2007) What influence has B-cell depletion on viral infections?. Leukemia & Lymphoma 48:7, 1257-1258 Online publication date: 1-Jan-2007. Citation | Full Text | PDF (53 KB) | PDF Plus (54 KB) Bertrand Coiffier. (2006) Hepatitis B Virus Reactivation in Patients Receiving Chemotherapy for Cancer Treatment: Role of Lamivudine Prophylaxis. Cancer Investigation 24:5, 548-552 Online publication date: 1-Jan-2006. Summary | Full Text | PDF (60 KB) | PDF Plus (61 KB) |
|





TOC Alert